The United States Preventative Service Task Force (USPSTF) released their draft update to their 2012 prostate-specific antigen (PSA) screening recommendation.1

The draft proposes the recommendation that clinicians educate men ages 55 to 69 about the potential benefits and harms of PSA screening for prostate cancer.

There are insufficient data to provide specific PSA screening recommendations for African American men, who are known to have a higher risk of prostate cancer and prostate cancer-specific mortality.

The update changes the 2012 Grade D recommendation — that the risks outweigh the benefits — to Grade C.

RELATED: PSA Nadir Identifies High-risk Cases of Localized Prostate Cancer

The change was initiated by additional data demonstrating a decreased mortality risk associated with PSA screening, though the risk-benefit ratio is closely balanced, according to the USPSTF statement.

The public is invited to comment on the draft recommendations until May 8, 2017.

Reference

  1. Draft recommendation statement: prostate cancer: screening. US Preventive Services Task Force website. https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationStatementDraft/prostate-cancer-screening1. Accessed April 19, 2017.